Skip to main content
SpringerLink
Log in

Disorders Of Phosphate Metabolism

  • Chapter
Therapy of Renal Diseases and Related Disorders

  • 175 Accesses

Abstract

A 70-kg adult contains about 700 g of phosphorus. Eighty-five percent of this quantity is in bone, 14% in soft tissues, and the remainder is equally distributed between the teeth, blood, and extravascular fluids. The extracellular fluid pool of phosphorus is only about 600 mg.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lau K: Phosphate disorders. In: JP Kokko, RL Tanner, eds, Fluids and Electrolytes. WB Saunders, Philadelphia, pp 398–471, 1986.

    Google Scholar 

  2. Lee DB, Kurokawa K: Physiology of phosphorus metabolism. In: MH Maxwell, CR Kleeman, RG Narins, eds, Clinical Disorders of Fluid and Electrolyte Metabolism, 4th ed. McGraw-Hill, New York, pp 245–295, 1987.

    Google Scholar 

  3. Slatopolsky E, Klahr S: Disorders of phosphorus, calcium and magnesium metabolism. 1988. In: RW Schrier, CW Gottschalk, ed., Diseases of the Kidney, 4th ed. Little, Brown, Boston, pp 2865–2920, 1988.

    Google Scholar 

  4. Quamme GA, Shapiro RJ: Membrane controls of epithelial phosphate transport. Can J Physiol Parmacol 65:275–286, 1987.

    Article  CAS  Google Scholar 

  5. Bonjour JP, Caverzasio J: Phosphate transport in the kidney. Rev Physiol Biochem Pharmacol 100:161–214, 1984.

    PubMed  CAS  Google Scholar 

  6. Mizgala CL, Quamme GA: Renal handling of phosphate. Physiological Rev 65:431–466, 1985.

    CAS  Google Scholar 

  7. Knox FG, Hamarati A: Renal regulation of phosphate excretion. In: DW Seldin, G Giebisch, eds, The Kidney: Physiology and Pathophysiology. Raven Press, New York, pp 1381–1396, 1985.

    Google Scholar 

  8. Gmaj P, Murer H: Cellular mechanisms of inorganic phosphate transport in kidney. Physiol Rev 66:376–370, 1986.

    Google Scholar 

  9. Hammerman MR: Phosphate transport across renal proximal tubular cell membranes. Am J Physiol 251:F385-F398, 1986.

    PubMed  CAS  Google Scholar 

  10. Kempson SA, Dousa TP: Current concepts of regulation of phosphate transport in renal proximal tubules. Biochem Pharmacol 35:721–726, 1986.

    Article  PubMed  CAS  Google Scholar 

  11. Sacktor B, Kinsella JL: Hormonal effects on sodium co-transport systems. Ann NY Acad Sci 456:438–444, 1986.

    Article  Google Scholar 

  12. Murer H, Malstrom K: How renal phosphate transport is regulated. NIPS 2:45–48, 1987.

    Google Scholar 

  13. Knochel JP: Deranged phosphorus metabolism. In: DW Seldin, G Giebisch, eds, The Kidney: Physiology and Pathophysiology. Raven Press, New York, pp 1397–1416, 1985.

    Google Scholar 

  14. Knochel JP, Jacobson HR: Renal handling of phosphorus, clinical hypophosphatemia, and phosphorus deficiency. In: BM Brenner, FC Rector Jr eds, The Kidney, 3rd ed. WB Saunders, Philadelphia pp 619–662, 1986.

    Google Scholar 

  15. Brautbar N, Kleeman CR: Hypophosphatemia and hyperphosphatemia: Clinical and pathophysiologic aspects. In: MH Maxwell, CR Kleeman, RG Narins, eds, Clinical Disorders of Fluid and Electrolyte Metabolism, 4th ed. McGraw-Hill, New York, pp 789–830, 1987.

    Google Scholar 

  16. Betro MG, Pain RW: Hypophosphataemia and hyperphos-phataemia in a hospital population. Br Med J 1:273–276, 1972.

    Article  PubMed  CAS  Google Scholar 

  17. Juan D, Elrazak MA: Hypophosphatemia in hospitalized patients. JAMA 242:163–164, 1979.

    Article  PubMed  CAS  Google Scholar 

  18. Larsson L, Rebel K, Sorbo B: Severe hypophosphatemia — A hospital survey. Acta Med Scand 214:221–223, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. King AL, Sica DA, Miller G, Pierpaoli S: Severe hypophosphatemia in a general hospital population. Southern Med J 80:831–835, 1987.

    Article  PubMed  CAS  Google Scholar 

  20. Trivedi B, Sanforth WH. Effect of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem 211:4110–4114, 1966.

    Google Scholar 

  21. Mostellar ME, Tutle EP. Effect of alkalosis on plasma and urinary excretion of inorganic phosphate in man. J Clin Invest 43:138–151, 1964.

    Article  PubMed  CAS  Google Scholar 

  22. Hoppe A, Metier M, Berndt TJ, Knox FG, Angielski S: Effect of respiratory alkalosis on renal phosphate excretion. Am J Physiol 241 (Renal Fluid Electrolyte Physiol 12):F471–F475, 1982.

    Google Scholar 

  23. Brautbar N, Leibovici H, Massry SG: On the mechanism of hypophosphatemia during acute hyperventilation: Evidence for increased muscle glycolysis. Min Elect Metab 9:45–50, 1983.

    CAS  Google Scholar 

  24. Lichtman MA, Miller DR, Cohen J, Waterhouse C: Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia. Ann Intern Med 740: 562–568, 1971.

    Google Scholar 

  25. Travis SF, Sugerman HJ, Ruberg FL, Dudrick SJ, Delivoria-Papadopoulos M, Miller LD, Oski FA: Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation. Engl J Med 285:763–768, 1971.

    Article  CAS  Google Scholar 

  26. Silvis SE, DiBartolomeo AG, Aaker HM: Hypophosphatemia and neurological changes secondary to oral caloric intake. A variant of hyperalimentation syndrome. Am J Gastroenterol 73:215–222, 1980.

    PubMed  CAS  Google Scholar 

  27. Weinsier RL, Krumdieck CL: Death resulting from over-zealous total parenteral nutrition: The refeeding syndrome revisited. Am J Clin Nutrition 34:393–399, 1980.

    Google Scholar 

  28. Kalbfleisch JM, Lindeman RD, Ginn HE, Smith WO: Effects of ethanol administration on urinary excretion of magnesium and other electrolytes in alcoholic and normal subjects. J Clin Invest 42:1471–1475, 1963.

    Article  PubMed  CAS  Google Scholar 

  29. Stein JH, Smith WO, Ginn HE: Hypophosphatemia in acute alcoholism. Am J Med Sci 252:78–83, 1966.

    Article  PubMed  CAS  Google Scholar 

  30. Blachley JD, Ferguson ER, Carter NW, Knochel JP: Chronic alcohol ingestion induces phosphorus deficiency and myopathy in the dog. Trans Assoc Am Physic 93:110–122, 1980.

    CAS  Google Scholar 

  31. Knochel JP: Hypophosphatemia in the alcoholic. Arch Intern Med 140:613–615, 1980.

    Article  PubMed  CAS  Google Scholar 

  32. Ryback RS, Eckardt MJ, Paulter CP: Clinical relationships between serum phosphorus and other blood chemistry values in alcoholics. Arc Intern Med 140:673–677, 1980.

    Article  CAS  Google Scholar 

  33. Adler AJ, Gudis S, Berlyne GM: Reduced renal phosphate threshold concentration in alcoholic cirrhosis. Min Electrolyte Metab 10:63–66, 1984.

    CAS  Google Scholar 

  34. De Marchi S, Cecchin E, Grimaldi F: Reduced renal phosphate threshold concentration in chronic alcoholics: One component of a more complex tubule dysfunction? Min Electrolyte Metab 12:147–148, 1986.

    Google Scholar 

  35. Schafer RM, Teschner M, Heidland A: Alterations of water, electrolyte and acid-base homeostasis in the alcoholic. Mineral Electrolyte Metab 13:1–6, 1987.

    Google Scholar 

  36. Kebler R, McDonald FD, Cadnapaphornchai P: Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med 79:571–576, 1985.

    Article  PubMed  CAS  Google Scholar 

  37. Levy LA: Severe hypophosphatemia as a complication of the treatment of hypothermia. Arch Intern Med 140:128–129, 1980.

    Article  PubMed  CAS  Google Scholar 

  38. Zamkoff KW, Kirshner JJ: Marked hypophosphatemia associated with acute myelomonocytic leukemia. Indirect evidence of phosphorus uptake by leukemic cells. Arch Intern Med 140:1523–1524, 1980.

    Article  PubMed  CAS  Google Scholar 

  39. Matzner Y, Prococimer M, Polliack A, Rubinger D, Popovtzer MM: Hypophosphatemia in a patient with lymphoma in leukemic phase. Arch Intern Med 141:805–806, 1981.

    Article  PubMed  CAS  Google Scholar 

  40. Aderka D, Shoenfeld Y, Santo M, Berliner S, Shaklai M, Weinberger A, Pinkhas J: Life-threatening hypophosphatemia in a patient with acute myelogenous leukemia. Acta Haemat 64:117–119, 1980.

    Article  PubMed  CAS  Google Scholar 

  41. Lenquist S, Lindell B, Nordstrom H, Sjoberg HE: Hypophosphatemia in severe burns. Acta Chir Scand 145:1–6, 1979.

    Google Scholar 

  42. Moorhead JF, Ahmed KY, Varghese Z, Willis MR, Baillod RA, Tatler GLV: Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet 20:694–697, 1974.

    Article  Google Scholar 

  43. Ward HN, Pabico RC, McKenna BA, Freeman RB: The renal handling of phosphate by renal transplant patients: Correlation with serum parathyroid hormone (SPTH), cyclic 3′,5′-adenosine monophosphate (cAMP) urinary excretion, and allograft function. Adv Exp Med Biol 81:173–181, 1977.

    PubMed  CAS  Google Scholar 

  44. Nielsen HE, Christensen MS, Meisen F, Torring S: Bone disease, hypophosphatemia and hyperpharathyroidism after renal transplantation. Adv Exp Med Biol 81:603–610, 1977.

    PubMed  CAS  Google Scholar 

  45. Farrington K, Varghese Z, Newman SP, Affmi KY, Fernando ON, Moorhead JF: Dissociation of absorptions of calcium and phosphate after successful cadaveric renal transplantation. Br Med J 1:712–714, 1979.

    Article  PubMed  CAS  Google Scholar 

  46. Nielsen HE, Meisen F, Christiensen MS: Spontaneous fractures following renal transplantation. Clinical and biochemical aspects, bone mineral content and bone morphometry. Min Elect Metab 2:323–330, 1979.

    Google Scholar 

  47. Walker GS, Peacock M, Marshall DH, Giles GR, Davison AM: Factors influencing the intestinal absorption of calcium and phosphorus following renal transplantation. Nephron 26:225–229, 1986.

    Article  Google Scholar 

  48. Kovarik J, Graf H, Stummvoll HK, Wolf A, Pinggera WF: Tubular phosphate handling after successful kidney transplantation. Klin Wochenschr 58:863–869, 1980.

    Article  PubMed  CAS  Google Scholar 

  49. Friedman A, Chesney R: Fanconi’s syndrome in renal transplantation. Am J Nephrol 1:45–47, 1981.

    Article  PubMed  CAS  Google Scholar 

  50. Rosenbaum RW, Hruska KA, Korkor A, Anderson C, Slatopolsky E: Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int 19:568–578, 1981.

    Article  PubMed  CAS  Google Scholar 

  51. Lucas PA, Brown RC, Bloodworth L, Woodhead JS: Vitamin D3 metabolites in hypercalcemic adults after kidney transplantation. Proc EDTA 20:213–219, 1983.

    CAS  Google Scholar 

  52. Bonomini V, Feletti C, Di Felice A, Buscaroli A: Bone remodelling after renal transplantation. Adv Exp Med Biol 178:207–216, 1984.

    PubMed  CAS  Google Scholar 

  53. Sakhaee K, Brinker K, Helderman JH, Bengfort JL, Nicar MJ, Hull AR, Pak CYC: Disturbances in mineral metabolism after successful renal transplantation. Min Elect Metab 11: 167–172, 1985.

    CAS  Google Scholar 

  54. Felsenfeld AJ, Gutman RA, Drezner M, Llach F: Hypophosphatemia in long-term renal transplant recipients: Effects on bone histology and 1,25-dihydroxycholecalciferol. Min Elect Metab 12:333–341, 1986.

    CAS  Google Scholar 

  55. Parfit AM, Kleerekoper M, Cruz C. Reduced phosphate reabsorption urelated to parathyroid hormone after renal transplantation: Implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Min Elect Metab 12:356–362, 1986.

    Google Scholar 

  56. Stoff JS: Phosphate homeostasis and hypophosphatemia. Am J Med 72:489–495, 1982.

    Article  PubMed  CAS  Google Scholar 

  57. Knochel JP: Neuromuscular manifestations of electrolyte disorders Am J Med 72:521–535, 1982.

    Article  PubMed  CAS  Google Scholar 

  58. Venditti FJ, Marotta C, Panezai FR. Olderwurtel HA, Regan TJ: Hypophosphatemia and cardiac arrhythmias. Min Elect Metab 13:19–25, 1987.

    CAS  Google Scholar 

  59. Aubier M, Murciano D, Lecocguic Y, Vires N, Jacquens Y, Squara P, Pariente R: Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 313:420–424, 1985.

    Article  PubMed  CAS  Google Scholar 

  60. Rie MA: Hypophosphatemia and diaphragmatic contractility. N Engl J Med 314:519–520, 1986.

    Article  PubMed  CAS  Google Scholar 

  61. Hasselstrom L, Wimberley PD, Nielsen VG: Hypophosphatemia and acute respiratory failure in a diabetic patient. Intensive Care Med 12:429–431, 1986.

    Article  PubMed  CAS  Google Scholar 

  62. Lumlertgul D, Harris DCH, Burke TJ, Schrier RW: Detrimental effect of hypophosphatemia on the severity and progression of ischemic acute renal failure. Min Elect Metab 12:204–209, 1986.

    CAS  Google Scholar 

  63. Kanter Y, Gerson JR, Bessman AN: 2,3-diphosphoglycerate, nucleotide phosphate, and organic and inorganic phosphate levels during the early phases of diabetic ketoacidosis. Diabetes 26:429–433, 1977.

    Article  PubMed  CAS  Google Scholar 

  64. Keller U, Berger W: Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes 87–95, 1979.

    Google Scholar 

  65. Wilson HK, Keuer SP, Lea AS, Boyd AE, Eknoyan G: Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 142:517–520, 1982.

    Article  PubMed  CAS  Google Scholar 

  66. Fisher JN, Kitabchi AE: A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol metab 57:177–180, 1983.

    Article  PubMed  CAS  Google Scholar 

  67. Kono N, Kuwajima M, Tarui S: Alteration of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase. Diabetes 30:346–353, 1981.

    Article  PubMed  CAS  Google Scholar 

  68. Lentz RD, Brown DM, Kjellstrand CM: Treatment of severe hypophosphatemia. Ann Intern Med 89:941–944, 1978.

    PubMed  CAS  Google Scholar 

  69. Vannatta JB, Whang R, Papper S: Efficacy of intravenous phosphorus therapy in the severly hypophosphatemic patient. Arch Intern Med 141:885–887, 1981.

    Article  PubMed  CAS  Google Scholar 

  70. Mallette LE, Mechanick JI: Heritable syndrome of pseudoxanthoma elasticum with abnormal phosphorus and vitamin D metabolism. Am J Med 83:1157–1162, 1987.

    Article  PubMed  CAS  Google Scholar 

  71. Weisinger JR, Mogollon A, Lander R, Bellorin-Font E, Riera R, Abadi I, Paz-Martinez R: Massive cerebral calcifications associated with increased renal phosphate reabsorption. Arch Intern Med 146:473–477, 1986.

    Article  PubMed  CAS  Google Scholar 

  72. Takuwa Y, Yamamoto M, Matsumoto T, Hata K, Ogata E: Hyperphosphatemia after surgical correction of hypercorto-solism in patients with Cushing’s syndrome. Min Elect Metab 12:119–124, 1986.

    CAS  Google Scholar 

  73. Challa A, Norrwall AA, Bevington A, Russell RGG: Cellular phosphate metabolism in patients receiving biophosphonate therapy. Bone 7:255–259, 1986.

    Article  PubMed  CAS  Google Scholar 

  74. Martin RR, Lisehora GR, Braxton M, Barcia PJ: Fatal poisoning from sodium phosphate enema. JAMA 257:2190–2192, 1987.

    Article  PubMed  CAS  Google Scholar 

  75. Suzuki NT: Hyperphosphatemia in nondialyzed TPN patients. J Parenter Enter Nutrition 11:512, 1987.

    Article  CAS  Google Scholar 

  76. Barsotti G, Lazzeri M, Cristofano C, Cerri M, Lupetti S, Giovannetti S: The role of metabolic acidosis in causing uremic hyperphosphatemia. Min Elect Metab 12:103–106, 1986.

    CAS  Google Scholar 

  77. De Marchi S, Cecchin E: More on the role of metabolic acidosis in causing uremic hyperphosphatemia. Min Elect Metab 13:67–68, 1987.

    Google Scholar 

  78. Stark ME, Dyer MCD, Coonley CJ: Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer 60:762–764, 1987.

    Article  PubMed  CAS  Google Scholar 

  79. Lumlertgul D, Burke TJ, Gillum DM, Alfrey AC, Harris DC, Hammond WS, Schrier RW: Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney Int 29:658–666, 1986.

    Article  PubMed  CAS  Google Scholar 

  80. Delmez JA, Fallon MD, Harter HR, Hruska KA, Slatopolsky E, Teitelbaum SL: Does strict phosphorus control precipitate renal osteomalacia? J Clin Endocrinol metab 62:747–752, 1986.

    Article  PubMed  CAS  Google Scholar 

  81. Slatopolsky E: The interaction of parathyroid hormone and alumimum in renal osteodystrophy. Kidney Int 31:842–854, 1987.

    Article  PubMed  CAS  Google Scholar 

  82. Burnatowska-Hledin MA, Doyle TM, Eadie MJ, Mayor GH: 1,25-dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats. J Lab Clin Med 108:96–102, 1986.

    PubMed  CAS  Google Scholar 

  83. Slanina P, Freeh W, Ekstrom L-G, Loof L, Slorach S, Cedergren A: Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem 32:539–541, 1986.

    PubMed  CAS  Google Scholar 

  84. Weberg R, Berstad A: Gastrointestinal absorption of aluminum from single doses of aluminum containing antacids in man. Eur J Clin Invest 16:428–432, 1986.

    Article  PubMed  CAS  Google Scholar 

  85. O’Donovan R, Hammer M, Baldwin D, Moniz C, Parsons V: Substitution of aluminum salts by magnesium salts in control of dialysis hyperphosphatemia. Lancet 19:880–882, 1986.

    Article  Google Scholar 

  86. Jennings AE, Bodvarsson M, Galicka-Piskorsha G, Difendorf AS, Simon GM, Levey AS: Use of magnesium hydroxide and low magnesium dialysate does not permit reduction of aluminum hydroxide during continuous ambulatory peritoneal dialysis. Am J Kid Dis 8:192–195, 1986.

    PubMed  CAS  Google Scholar 

  87. Ramirez JA, Emmett M, White MG, Fathi N, Santa Ana CA, Morawski SG, Fordtran JS: The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Internat 30:753–759, 1986.

    Article  CAS  Google Scholar 

  88. Fournier A, Moriniere P, Sebert JL, Dkhissi H, Atik A, Leflon P, Renaud H, Gueris J, Gregoire I, Idrissi A, Garabe-dian M: Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia. Kidney to 29: S114–S119, 19

    Google Scholar 

  89. Taber TE, Hegmen TF, York S: Calcium carbonate as a phosphate binder in hemodialysis patients. Trans Am Soc Artif Intern Organs 32:127–129, 1986.

    CAS  Google Scholar 

  90. Salusky IB, Coburn JW, Foley J, Nelson P, Fine RN: Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. J Pediat 5:767–770, 1986.

    Article  Google Scholar 

  91. Alon U, Davidai G, Bentur L, Berant M, Better OS: Oral calcium carbonate as phosphate-binder in patients and children with chronic renal failure. Min Elect Metab 12:320–325, 1986.

    CAS  Google Scholar 

  92. Herez G, Kraut JA, Andress DA, Howard N, Roberts C, Shinaberger JH, Sherrard DJ, Coburn JW: Use of calcium carbonate as a phosphate binder in dialysis patients. Min Elect Metab 12:314–319, 1986.

    Google Scholar 

  93. Andreoll SP, Dunson JW, Bergstein JM: Calcium carbonate is an effective phosphorus binder in children with chronic renal failure. Am J Kid Dis 3:206–210, 1987.

    Google Scholar 

  94. Stein HD, Yudis M, Sirota RA: Calcium carbonate as a phosphate binder. N Engl J Med 316:109–110, 1987.

    Article  Google Scholar 

  95. Almirall J, Campistol JM, Torras A, Revert L: Calcium carbonate as phosphate binder in dialysis. Lancet 10:799–800, 1987.

    Article  Google Scholar 

  96. Cushner HM, Copley JB, Lindberg JS, Foulks CJ: Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF. Kidney Int 33:95–99, 1988.

    Article  PubMed  CAS  Google Scholar 

  97. Schneider HW, Kulbe KD, Weber H, Streicher E: In vitro and in vivo studies with a non-aluminum phosphate-binding compound. Kidney Int 29 (Suppl 18):S120-S123, 1986.

    Google Scholar 

  98. Larson EA, Ash SR, White JL, Hem SI: Phosphate binding gels: Balancing phosphate absorption and aluminum toxicity. Kidney Int 29:1131–1135, 1986.

    Article  PubMed  CAS  Google Scholar 

  99. Vucelic B, Hadzic N, Gragas J, Puretic Z: Changes in serum phosphorus, calcium and alkaline phosphatase due to sucralfate. Int J Clin Pharm Therapy Toxicol 24:93–96, 1988.

    Google Scholar 

Download references

Authors
  1. Moshe Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James P. Knochel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA

    Wadi N. Suki

  2. Division of Nephrology, University of Southern California, Los Angeles, California, USA

    Shaul G. Massry

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Kluwer Academic Publishers

About this chapter

Cite this chapter

Levi, M., Knochel, J.P. (1991). Disorders Of Phosphate Metabolism. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0689-4_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8027-9

  • Online ISBN: 978-1-4613-0689-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation